Authors
Latest:
Pharmacists Help Patients Manage Chronic PainChronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.
Latest:
Protecting Our Most Vulnerable Through VaccinationFor more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.
Latest:
Pharmacist Discusses Vaccine Guidance Uncertainty Following ACIP RemovalCherokee Layson-Wolf, PharmD, BCACP, FAPhA, highlights the critical role pharmacists play in navigating vaccine recommendations and supporting patient understanding.
Latest:
Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common ColdDespite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Latest:
New Advances in Breast Cancer TherapyBreast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.
Latest:
Two Eye Diseases Could Contribute to Common Blinding Eye ConditionThe study could lead to early diagnosis and treatment of age-related macular degeneration.
Latest:
Preventing Severe Respiratory Infections in ChildrenA refresher on best interventions for common respiratory disorders in children.
Latest:
Focus on DIR Fees: 3 Ways to Manage ThemWhen investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.
Latest:
Maximizing Adherence Packaging for Patient Health and Pharmacy GrowthIs adherence packaging technology a big investment for a community or independent pharmacy?
Latest:
OTC Drug Interaction Considerations in the Cough and Cold AisleOTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.
Latest:
Q&A: Expert Discusses the Critical Role of Clinical Pharmacists in Diabetes ManagementClinical pharmacists transform diabetes care by leveraging manufacturer-sponsored patient assistance programs to dramatically improve medication access.
Latest:
Focus on What Matters: Sustaining Your Pharmacy in 2025What are some key strategies for keeping your pharmacy thriving in 2025?
Latest:
Navigating Pediatric ADHD Medication ShortagesStimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Latest:
Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference ProductFindings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.
Latest:
Case Study: Treating Infants for Cannabis ExposureAs more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.
Latest:
Cannabinoid Hyperemesis Syndrome: Diagnosis and ManagementA deep dive for pharmacists into this frequently debilitating disorder
Latest:
Pharmacists Discuss Their Hopes for the Future of Pharmacy in 2025 | APhA 2025Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.
Latest:
Creating A Successful Social Media PresenceSocial media is a great way to gain exposure, but there are many dos-and-don’ts to understand when signing up for a social platform.
Latest:
COVID-19 Vaccines: T Cell, Antibody Responses Demonstrated in CLLPatients with chronic lymphocytic leukemia experienced functional T cell and antibody responses after receiving a vaccine for COVID-19.
Latest:
Breaking Down the Numbers for Isotretinoin AEsRecent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.
Latest:
Biosimilars Are Bringing Affordability and AccessibilityLower costs, increased availability, and assistance programs are “game changers” for patients.
Latest:
Why Is There Such A Large Disparity In Who Meets Critera For Hepatitis B Treatment?Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.
Latest:
New Drug Review: Atogepant FDA-Approved for Migraine TreatmentOn September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.
Latest:
Scripted for Her: Helping Patients Choose Contraceptive MethodsIn this episode of the podcast, Natalie DiPietro Mager, PharmD, PhD, sits down with Jasmine Cutler, PharmD, CPh.
Latest:
The Pharmacist’s Role in Counseling Patients on GLP-1 MedicationsWith expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.
Latest:
DefenCath Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in AdultsThis new drug utilizes the bactericidal properties of taurolidine and the bloodthinning effects of heparin to maintain catheter patency.
Latest:
Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget CutsWith the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.
Latest:
OTC Considerations for COVID-19Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves
Latest:
Focus on DIR Fees: 3 Ways to Manage ThemWhen investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.
